Table 1. CHIP staining and clinicopathological characteristics of 304 renal cancer patients.
CHIP staining |
||||
---|---|---|---|---|
Variables | Negative (%) | Positive (%) | Total | P* |
All cases | 154 (34.7) | 150 (49.3) | 304 | |
Age | ||||
≤ 56 years | 69 (47.6) | 76 (52.4) | 145 | 0.182 |
> 56 years | 85 (53.5) | 74 (46.5) | 159 | |
Gender | ||||
Male | 100 (49.5) | 102 (50.5) | 202 | 0.328 |
Female | 54 (52.9) | 48 (47.1) | 102 | |
Tumor size | ||||
≤ 7 cm | 114 (48.3) | 122 (51.7) | 236 | 0.082 |
> 7 cm | 40 (58.8) | 28 (41.2) | 68 | |
pT status | ||||
pT1 | 92 (46.2) | 107 (53.8) | 199 | 0.022 |
pT2- pT4 | 62 (59.0) | 43 (41.0) | 105 | |
pN status | ||||
pN0 | 142 (51.1) | 136 (48.9) | 278 | 0.123 |
pN1- pN3 | 7 (35.0) | 13 (65.0) | 20 | |
pM status | ||||
pM0 | 132 (51.8) | 123 (48.2) | 255 | 0.332 |
pM1 | 3 (37.5) | 5 (62.5) | 8 | |
TNM stage | ||||
I | 82 (45.6) | 98 (54.4) | 180 | 0.022 |
II-IV | 54 (59.3) | 37 (40.7) | 91 |
*Two sided Fisher's exact tests.